HEARING
Maintaining America’s Leadership in Biomedical Innovation: FDA’s Role in Advancing U.S. Drug Development.
Schedule
- Date and time (ET)
- July 15, 2026 at 10:15 AM
- Location
- Rayburn House Office Building · 2123
Witnesses
Dr. Cynthia Verst
President, Design and Delivery Innovation, R&D Solutions, IQVIA
Ms. Susan Winckler
CEO, Reagan-Udall Foundation for the FDA
Dr. Aaron Kowalski
CEO, Breakthrough T1D
Dr. Thomas Hwang
Assistant Professor of Medicine, Brigham and Women's Hospital and Harvard Medical School
Mr. Thomas Bollyky
Bloomberg Chair in Global Health, Senior Fellow for International Economics, Law, and Development; and Director of the Global Health Program, Council
